SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 5 filers reported holding SIO GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,225 | -78.3% | 235,000 | -86.0% | 0.00% | -75.0% |
| Q3 2022 | $471,000 | -22.1% | 1,680,536 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $605,000 | -46.3% | 1,680,536 | -0.1% | 0.01% | -66.7% |
| Q1 2022 | $1,127,000 | -51.5% | 1,682,000 | -6.6% | 0.02% | -37.5% |
| Q4 2021 | $2,322,000 | -36.3% | 1,800,000 | +7.1% | 0.02% | -51.0% |
| Q3 2021 | $3,646,000 | -13.3% | 1,680,000 | +9.1% | 0.05% | -3.9% |
| Q2 2021 | $4,204,000 | +0.7% | 1,540,000 | -3.8% | 0.05% | 0.0% |
| Q1 2021 | $4,176,000 | -53.1% | 1,600,000 | -50.0% | 0.05% | +6.2% |
| Q4 2020 | $8,896,000 | – | 3,200,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
| Prosight Management, LP | 670,300 | $449,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
| Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
| Clearline Capital LP | 392,691 | $263,000 | 0.03% |
| APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
| Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
| NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |